Amir Aghajanian is a Cardiology physician affiliated with University of North Carolina at Chapel Hill. OpenAlex indexes 22 publications with 831 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingMedicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80.3%Beta blocker20.7%Metoprolol Succinate74%Carvedilol15%Metoprolol Tartrate6%Atenolol2%Sotalol2%Part D<11 patientsStatin13.1%Atorvastatin Calcium74%Rosuvastatin Calcium21%Pravastatin Sodium5%Part D≥102 patients+ 14 more classes in this area
Blood & clotting
18.4%Factor Xa inhibitor16%Eliquis75%Xarelto25%Part D≥82 patientsP2Y12 inhibitor2.4%Clopidogrel88%Brilinta12%Part D<11 patientsMetabolism & gastrointestinal
1.3%SGLT2 inhibitor0.7%Jardiance100%Part D<11 patientsPotassium supplement0.6%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2009–2012 per NIH RePORTER. The latest:
- Redox Regulation of RhoA and Modulation of Vascular Permeability
Univ of North Carolina Chapel Hill
FY2012$33,229F30HL094063 - Redox Regulation of RhoA and Modulation of Vascular Permeability
Univ of North Carolina Chapel Hill
FY2011$32,797F30HL094063 - Redox Regulation of RhoA and Modulation of Vascular Permeability
Univ of North Carolina Chapel Hill
FY2010$28,658F30HL094063
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Lisa Carey, MD
University of North Carolina at Chapel Hill
Robert Sandler, MD
University of North Carolina at Chapel Hill
Diana Perkins, MD
University of North Carolina at Chapel Hill
Hyman Muss, MD
University of North Carolina at Chapel Hill
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”